» Articles » PMID: 30332804

Grinding As Solvent-Free Green Chemistry Approach for Cyclodextrin Inclusion Complex Preparation in the Solid State

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2018 Oct 19
PMID 30332804
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Among the different techniques proposed for preparing cyclodextrin inclusion complex in the solid state, mechanochemical activation by grinding appears as a fast, highly efficient, convenient, versatile, sustainable, and eco-friendly solvent-free method. This review is intended to give a systematic overview of the currently available data in this field, highlighting both the advantages as well as the shortcomings of such an approach. The possible mechanisms involved in the inclusion complex formation in the solid state, by grinding, have been illustrated. For each type of applied milling device, the respective process variables have been examined and discussed, together with the characteristics of the obtained products, also in relation with the physicochemical characteristics of both the drug and cyclodextrin subjected to grinding. The critical process parameters were evidenced in order to provide a useful guide for a rational selection of the most suitable conditions for an efficient inclusion complex preparation by grinding, with the final purpose of promoting a wider use of this effective solvent-free cyclodextrin inclusion complex preparation method in the solid state.

Citing Articles

Biopharmaceutical Characterization and Stability of Nabumetone-Cyclodextrins Complexes Prepared by Grinding.

Klaric D, Soldin Z, Vincze A, Szollath R, Balogh G, Jug M Pharmaceutics. 2025; 16(12.

PMID: 39771473 PMC: 11679744. DOI: 10.3390/pharmaceutics16121493.


Pediatric Orally Disintegrating Tablets (ODTs) with Enhanced Palatability Based on Propranolol HCl Coground with Hydroxypropyl-β-Cyclodextrin.

Cirri M, Mura P, Maestrelli F, Benedetti S, Buratti S Pharmaceutics. 2024; 16(11).

PMID: 39598476 PMC: 11597579. DOI: 10.3390/pharmaceutics16111351.


Complexation by γ-cyclodextrin as a way of improving anticancer potential of sumanene.

Kasprzak A, Zuchowska A, Sakurai H Sci Rep. 2024; 14(1):27158.

PMID: 39511291 PMC: 11543856. DOI: 10.1038/s41598-024-78110-1.


Polymeric Amorphous Solid Dispersions of Dasatinib: Formulation and Ecotoxicological Assessment.

Sokac K, Miloloza M, Kucic Grgic D, Zizek K Pharmaceutics. 2024; 16(4).

PMID: 38675212 PMC: 11053848. DOI: 10.3390/pharmaceutics16040551.


Ternary cyclodextrin systems of terbinafine hydrochloride inclusion complexes: Solventless preparation, solid-state, and in vitro characterization.

Kondoros B, Kokai D, Burian K, Sorrenti M, Catenacci L, Csoka I Heliyon. 2023; 9(11):e21416.

PMID: 38027871 PMC: 10663756. DOI: 10.1016/j.heliyon.2023.e21416.


References
1.
Higashi K, Tozuka Y, Moribe K, Yamamoto K . Salicylic acid/gamma-cyclodextrin 2:1 and 4:1 complex formation by sealed-heating method. J Pharm Sci. 2010; 99(10):4192-200. DOI: 10.1002/jps.22133. View

2.
Mura P . Analytical techniques for characterization of cyclodextrin complexes in the solid state: A review. J Pharm Biomed Anal. 2015; 113:226-38. DOI: 10.1016/j.jpba.2015.01.058. View

3.
Aigner Z, Berkesi O, Farkas G, Szabo-Revesz P . DSC, X-ray and FTIR studies of a gemfibrozil/dimethyl-β-cyclodextrin inclusion complex produced by co-grinding. J Pharm Biomed Anal. 2011; 57:62-7. DOI: 10.1016/j.jpba.2011.08.034. View

4.
Jug M, Maestrelli F, Bragagni M, Mura P . Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery. J Pharm Biomed Anal. 2009; 52(1):9-18. DOI: 10.1016/j.jpba.2009.11.013. View

5.
Miller L, Carrier R, Ahmed I . Practical considerations in development of solid dosage forms that contain cyclodextrin. J Pharm Sci. 2007; 96(7):1691-707. DOI: 10.1002/jps.20831. View